Results 21 to 30 of about 26,219 (238)
A case of Kaposi’s sarcoma of tonsil with profuse bleeding in an HIV-positive patient
SAGE Open Medical Case Reports, 2021 Kaposi’s sarcoma is the most common AIDS-associated malignancy. Kaposi’s sarcoma in the oral cavity and oropharynx present as a macular, papular, or nodular lesion on the palate, gingiva, or tongue which may look pink, reddish, or purplish.
Dorji Penjor, Aun Wee Chong
doaj +1 more source
Scrotal Kaposi's Sarcoma in HIV-negative Patient: A Case Report and Review of the Literature.
Albanian Journal of Trauma and Emergency Surgery, 2023 Background: Kaposi's sarcoma (KS) is an indolent angio-proliferative tumor proliferation with spindle cells originating from endothelial and immune cells infected with human herpes virus type 8. (HHV-8: also known as Kaposi sarcoma herpes virus [KSHV]).
Teona Bushati +5 more
doaj +1 more source
Journal of Global Health Reports, 2021 # Background Kaposi’s sarcoma became prevalent with the appearance of human immune deficiency virus (HIV) in the 1980s. However, the widespread use of the highly active antiretroviral therapy (HAART) reduced its prevalence in communities with good ...
Jonathan C Daboer +4 more
doaj +1 more source
Classic Kaposi's sarcoma treated with elastic stockings and outpatient follow-up of a 90-year-old patient [PDF]
Anais Brasileiros de Dermatologia, 2013 Kaposi's sarcoma is a multifactorial angioproliferative disorder. The herpes virus 8 human contributes to its pathogenesis, but it is uncertain whether these lesions are only reactive hyperplasia to the virus or neoplasia.
Flavia Trevisan +3 more
doaj +1 more source
Frontiers in Cell and Developmental Biology, 2023 Kaposi’s sarcoma associated herpesvirus (KSHV) is causative agent of Kaposi’s sarcoma, Multicentric Castleman Disease and Pleural effusion lymphoma. KSHV-encoded ORF17 encodes a protease which cleaves -Ala-Ala-, -Ala-Ser- or -Ala-Thr-bonds.
Misbahuddin M Rafeeq +12 more
doaj +1 more source
Kaposi's sarcoma in an HIV-positive person successfully treated with paclitaxel [PDF]
, 2009 Epidemic Kaposi's sarcoma is one of the malignant neoplasms, which can develop in HIV-infected patients. Although the prevalence of HIV infection is reported to be high in Asian countries, Kaposi's sarcoma is rarely reported. We report a case of Kaposi's
Dongre, Atul, Montaldo, Chiara
core +1 more source
A case report of the rapid dissemination of Kaposi’s sarcoma in a patient with HIV
African Journal of Primary Health Care & Family Medicine, 2013 Introduction: Kaposi’s sarcoma is the most common HIV-associated neoplastic disease. In most cases it starts on the skin and later spreads to other visceral organs.
Indiran Govender +2 more
doaj +1 more source
Brazilian Journal of Infectious Diseases, 2014 Kaposi's sarcoma is a multifocal vascular lesion of low-grade potential that is most often present in mucocutaneous sites and usually also affects lymph nodes and visceral organs.
Érico Arruda +17 more
doaj +1 more source
Archives of Pathology & Laboratory Medicine, 2013 Kaposi sarcoma (KS) is a low-grade vascular tumor associated with Kaposi sarcoma herpesvirus/human herpesvirus 8 (KSHV/HHV8) infection. Kaposi sarcoma lesions predominantly present at mucocutaneous sites, but may involve all organs and anatomic locations. Recognized epidemiologic-clinical forms of KS include classic, African (endemic), AIDS-associated (
Oana, Radu, Liron, Pantanowitz
openaire +2 more sources
Cancers, 2023 Kaposi’s sarcoma (KS) is a common neoplasm in Eastern and central Africa reflecting the spread of human gammaherpesvirus-8 (HHV-8), now considered a necessary causal agent for the development of KS. The endemic KS subtype can follow an aggressive clinical course with ulcerative skin lesions with soft tissue invasion or even bone or visceral involvement.
Perla El Zeinaty +2 more
openaire +2 more sources